Selecta Biosciences Inc

NASDAQ:SELB   3:59:57 PM EDT
4.44
+0.12 (+2.78%)
Other Pre-Announcement

Selecta Biosciences Reports Q2 Revenue Of $19.7 Mln

Published: 08/12/2021 12:34 GMT
Selecta Biosciences Inc (SELB) - Selecta Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Revenue $19.7 Million.
Q2 Revenue Estimate $7.1 Million -- Refinitiv Ibes Data (analyst estimates).
Selecta Biosciences - Cash, Cash Equivalents, Marketable Securities As of June 30, 2021 Expected to Provide Runway Into Q3 of 2023.
Qtrly Basic Net Income per Share of $0.04.
Qtrly Diluted Net Income per Share $0.00.